"But did you bleed him? - Aesculapius says that bleeding is not a cure. It is only a way of proving that you are a physician at the expense of your patient." Finally, we discuss the EPI-321 epigenetic editing phase I/II clinical trial design and its potential for answering key questions necessary for going to phase III and for providing benefit to participants and patients.
Podden och tillhörande omslagsbild på den här sidan tillhör
Peter L Jones, PhD. Innehållet i podden är skapat av Peter L Jones, PhD och inte av,
eller tillsammans med, Poddtoppen.
